A prospective clinical of lithium disilicate pressed zirconia and monolithic zirconia in posterior implant-supported prostheses: A 24-month follow-up / 대한치과보철학회지
The Journal of Korean Academy of Prosthodontics
;
: 134-141, 2019.
Artigo
em Coreano
| WPRIM
| ID: wpr-742105
ABSTRACT
PURPOSE:
The purpose of this study was to compare the clinical outcomes of lithium disilicate ceramic pressed zirconia prostheses and monolithic zirconia prostheses and to investigate the complications after two years of follow-up in posterior edentulous site. MATERIALS ANDMETHODS:
A total 17 patients (male 12, female 5) were treated with 60 posterior fixed implant-supported prostheses (LP. lithium disilicate ceramic pressed zirconia prostheses n = 30, MZ. monolithic zirconia prostheses n = 30). After 24-month, clinical examination of Implant survival rate, marginal bone resorption, probing depth, plaque index, bleeding index, calculus and complications were evaluated.RESULTS:
There were no failed implants and all implants were normal in function without mobility. Marginal bone resorption was lower in LP group than MZ group at 12-month (P < .05), and 12-month probing depth and calculus deposit in LP group were significantly higher than MZ group (P < .05). Most common complications in MZ were marginal bone resorptions more than 1.5.mm and 2 chipping occurred in LP group.CONCLUSION:
Within the limitations of the present study, lithium disilicate ceramic pressed zirconia is considered as a predictable treatment option as much as monolithic zirconia in posterior fixed implant-supported prostheses.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Próteses e Implantes
/
Reabsorção Óssea
/
Cálculos
/
Implantes Dentários
/
Cerâmica
/
Taxa de Sobrevida
/
Estudos Prospectivos
/
Seguimentos
/
Hemorragia
/
Lítio
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Limite:
Feminino
/
Humanos
Idioma:
Coreano
Revista:
The Journal of Korean Academy of Prosthodontics
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS